Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

527 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Dementia with lewy bodies: findings from an international multicentre study.
Del Ser T, McKeith I, Anand R, Cicin-Sain A, Ferrara R, Spiegel R. Del Ser T, et al. Among authors: spiegel r. Int J Geriatr Psychiatry. 2000 Nov;15(11):1034-45. doi: 10.1002/1099-1166(200011)15:11<1034::aid-gps231>3.0.co;2-5. Int J Geriatr Psychiatry. 2000. PMID: 11113984 Clinical Trial.
Effects of rivastigmine on cognitive function in dementia with lewy bodies: a randomised placebo-controlled international study using the cognitive drug research computerised assessment system.
Wesnes KA, McKeith IG, Ferrara R, Emre M, Del Ser T, Spano PF, Cicin-Sain A, Anand R, Spiegel R. Wesnes KA, et al. Among authors: spiegel r. Dement Geriatr Cogn Disord. 2002;13(3):183-92. doi: 10.1159/000048651. Dement Geriatr Cogn Disord. 2002. PMID: 11893841 Clinical Trial.
Rivastigmine in Alzheimer disease: efficacy over two years.
Grossberg G, Irwin P, Satlin A, Mesenbrink P, Spiegel R. Grossberg G, et al. Among authors: spiegel r. Am J Geriatr Psychiatry. 2004 Jul-Aug;12(4):420-31. doi: 10.1176/appi.ajgp.12.4.420. Am J Geriatr Psychiatry. 2004. PMID: 15249280 Clinical Trial.
Protocols to demonstrate slowing of Alzheimer disease progression. Position paper from the International Working Group on Harmonization of Dementia Drug Guidelines. The Disease Progression Sub-Group.
Bodick N, Forette F, Hadler D, Harvey RJ, Leber P, McKeith IG, Riekkinen PJ, Rossor MN, Scheltens P, Shimohama S, Spiegel R, Tanaka S, Thal LJ, Urata Y, Whitehouse P, Wilcock G. Bodick N, et al. Among authors: spiegel r. Alzheimer Dis Assoc Disord. 1997;11 Suppl 3:50-3. Alzheimer Dis Assoc Disord. 1997. PMID: 9305517
527 results